A pioneering dental medicine project in Japan is making strides toward clinical trials, with the aim of becoming the world’s first tooth-regrowing treatment, according to the country’s national news site Mainichi.
The upcoming trial will be focused on patients affected by anodontia, a genetic condition characterized by the absence of teeth, or partial anodontia, where people are missing some teeth, as described by the National Organization for Rare Disorders (NORD).
Clinical trials are scheduled to begin next July in Japan. If successful, regulatory approval for the tooth-regrowing medicine is anticipated by 2030, potentially heralding groundbreaking advancements in dentistry.
Comments are closed.